Preface |
|
xv | |
|
|
xix | |
|
Part I Methods for the Design and Optimization of New Active Ingredients |
|
|
1 | (128) |
|
1 High-Throughput Screening in Agrochemical Research |
|
|
3 | (18) |
|
|
|
|
|
3 | (3) |
|
1.2 Target-Based High-Throughput Screening |
|
|
6 | (7) |
|
|
6 | (3) |
|
1.2.2 High-Throughput Screening Techniques |
|
|
9 | (4) |
|
1.3 Other Screening Approaches |
|
|
13 | (1) |
|
1.3.1 High-Throughput Virtual Screening |
|
|
13 | (1) |
|
1.4 In Vivo High-Throughput Screening |
|
|
13 | (4) |
|
1.4.1 Compound Sourcing and In-Silico Screening |
|
|
15 | (2) |
|
|
17 | (4) |
|
|
18 | (1) |
|
|
18 | (3) |
|
2 Computational Approaches in Agricultural Research |
|
|
21 | (22) |
|
|
|
21 | (1) |
|
|
21 | (1) |
|
2.3 Ligand-Based Approaches |
|
|
22 | (4) |
|
2.4 Structure-Based Approaches |
|
|
26 | (7) |
|
2.5 Estimation of Adverse Effects |
|
|
33 | (1) |
|
|
34 | (1) |
|
2.7 Programs and Databases |
|
|
34 | (5) |
|
2.7.1 In-Silico Toxicology Models |
|
|
36 | (3) |
|
|
39 | (4) |
|
|
40 | (3) |
|
3 Quantum Chemical Methods in the Design of Agrochemicals |
|
|
43 | (30) |
|
|
|
43 | (1) |
|
3.2 Computational Quantum Chemistry: Basics, Challenges, and New Developments |
|
|
44 | (3) |
|
3.3 Minimum Energy Structures and Potential Energy Surfaces |
|
|
47 | (4) |
|
3.4 Physico-Chemical Properties |
|
|
51 | (9) |
|
3.4.1 Electrostatic Potential, Fukui Functions, and Frontier Orbitals |
|
|
53 | (2) |
|
3.4.2 Magnetic Properties |
|
|
55 | (2) |
|
|
57 | (2) |
|
3.4.4 Solvation Free Energies |
|
|
59 | (1) |
|
3.4.5 Absolute Configuration of Chiral Molecules |
|
|
60 | (1) |
|
3.5 Quantitative Structure-Activity Relationships |
|
|
60 | (6) |
|
3.5.1 Property Fields, Wavelets, and Multi-Resolution Analysis |
|
|
61 | (2) |
|
3.5.2 The CoMFA Steroid Dataset |
|
|
63 | (1) |
|
3.5.3 A Neonicotinoid Dataset |
|
|
64 | (2) |
|
|
66 | (7) |
|
|
67 | (6) |
|
4 The Unique Role of Halogen Substituents in the Design of Modern Crop Protection Compounds |
|
|
73 | (56) |
|
|
|
73 | (2) |
|
4.2 The Halogen Substituent Effect |
|
|
75 | (11) |
|
|
76 | (2) |
|
4.2.2 The Electronic Effect |
|
|
78 | (1) |
|
4.2.2.1 Electronegativities of Halogens and Selected Elements/Groups on the Pauling Scale |
|
|
78 | (1) |
|
4.2.2.2 Effect of Halogen Polarity of the C-Halogen Bond |
|
|
79 | (1) |
|
4.2.2.3 Effect of Halogens on pKa Value |
|
|
79 | (1) |
|
4.2.2.4 Improving Metabolic, Oxidative, and Thermal Stability with Halogens |
|
|
80 | (2) |
|
4.2.3 Effect of Halogens on Physico-Chemical Properties |
|
|
82 | (1) |
|
4.2.3.1 Effect of Halogens on Molecular Lipophilicity |
|
|
82 | (2) |
|
4.2.3.2 Classification in the Disjoint Principle Space |
|
|
84 | (1) |
|
4.2.4 Effect of Halogens on Shift of Biological Activity |
|
|
84 | (2) |
|
4.3 Insecticides and Acaricides Containing Halogens |
|
|
86 | (13) |
|
4.3.1 Voltage-Gated Sodium Channel (vgSCh) Modulators |
|
|
86 | (1) |
|
4.3.1.1 Pyrethroids of Type A |
|
|
86 | (3) |
|
4.3.1.2 Pyrethroids of Type B |
|
|
89 | (1) |
|
4.3.1.3 Pyrethroids of Type C |
|
|
90 | (1) |
|
4.3.2 Voltage-Gated Sodium Channel (vgSCh) Blockers |
|
|
90 | (1) |
|
4.3.3 Inhibitors of the y-Aminobutyric Acid (GABA) Receptor/Chloride Ionophore Complex |
|
|
91 | (2) |
|
4.3.4 Insect Growth Regulators (IGRs) |
|
|
93 | (3) |
|
4.3.5 Mitochondrial Respiratory Chain |
|
|
96 | (1) |
|
4.3.5.1 Inhibitors of Mitochondrial Electron Transport at Complex I |
|
|
96 | (1) |
|
4.3.5.2 Inhibitors of Q0 Site of Cytochrome bc1 - Complex III |
|
|
97 | (1) |
|
4.3.5.3 Inhibitors of Mitochondrial Oxidative Phosphorylation |
|
|
97 | (1) |
|
4.3.6 Ryanodine Receptor (RyR) Effectors |
|
|
98 | (1) |
|
4.4 Fungicides Containing Halogens |
|
|
99 | (9) |
|
4.4.1 Sterol Biosynthesis Inhibitors (SBIs) and Demethylation Inhibitors (DMIs) |
|
|
99 | (2) |
|
4.4.2 Mitochondrial Respiratory Chain |
|
|
101 | (1) |
|
4.4.2.1 Inhibitors of Succinate Dehydrogenase (SDH)- Complex II |
|
|
101 | (3) |
|
4.4.2.2 Inhibitors of Q0 Site of Cytochrome bc1 - Complex III |
|
|
104 | (3) |
|
4.4.2.3 NADH Inhibitors - Complex I |
|
|
107 | (1) |
|
4.4.3 Fungicides Acting on Signal Transduction |
|
|
107 | (1) |
|
4.5 Plant Growth Regulators (PGRs) Containing Halogens |
|
|
108 | (1) |
|
4.5.1 Reduction of Internode Elongation: Inhibition of Gibberellin Biosynthesis |
|
|
108 | (1) |
|
4.6 Herbicides Containing Halogens |
|
|
109 | (10) |
|
4.6.1 Inhibitors of Carotenoid Biosynthesis: Phytoene Desaturase (PDS) Inhibitors |
|
|
109 | (2) |
|
4.6.2 Inhibitors of Acetolactate Synthase (ALS) |
|
|
111 | (1) |
|
4.6.2.1 Sulfonylurea Herbicides |
|
|
111 | (4) |
|
4.6.2.2 Sulfonylaminocarbonyl-Triazolone Herbicides (SACTs) |
|
|
115 | (1) |
|
4.6.2.3 Triazolopyrimidine Herbicides |
|
|
116 | (1) |
|
4.6.3 Protoporphyrinogen IX Oxidase (PPO) |
|
|
117 | (2) |
|
|
119 | (10) |
|
|
119 | (10) |
|
Part II New Methods to Identify the Mode of Action of Active Ingredients |
|
|
129 | (88) |
|
5 RNA Interference (RNAi) for Functional Genomics Studies and as a Tool for Crop Protection |
|
|
131 | (30) |
|
|
|
|
|
131 | (1) |
|
5.2 RNA Silencing Pathways |
|
|
131 | (3) |
|
5.2.1 The MicroRNA (miRNA) Pathway |
|
|
133 | (1) |
|
5.2.2 The Small Interfering Pathway (siRNA) |
|
|
134 | (1) |
|
5.3 RNAi as a Tool for Functional Genomics in Plants |
|
|
134 | (4) |
|
5.4 RNAi as a Tool for Engineering Resistance against Fungi and Oomycetes |
|
|
138 | (2) |
|
5.5 RNAi as a Tool for Engineering Insect Resistance |
|
|
140 | (2) |
|
5.6 RNAi as a Tool for Engineering Nematodes Resistance |
|
|
142 | (2) |
|
5.7 RNAi as a Tool for Engineering Virus Resistance |
|
|
144 | (5) |
|
5.8 RNAi as a Tool for Engineering Bacteria Resistance |
|
|
149 | (1) |
|
5.9 RNAi as a Tool for Engineering Parasitic Weed Resistance |
|
|
150 | (3) |
|
5.10 RNAi Safety in Crop Plants |
|
|
153 | (1) |
|
|
153 | (8) |
|
|
153 | (8) |
|
6 Fast Identification of the Mode of Action of Herbicides by DNA Chips |
|
|
161 | (14) |
|
|
|
|
161 | (1) |
|
6.2 Gene Expression Profiling: A Method to Measure Changes of the Complete Transcriptome |
|
|
162 | (2) |
|
6.3 Classification of the Mode of Action of an Herbicide |
|
|
164 | (1) |
|
6.4 Identification of Prodrugs by Gene Expression Profiling |
|
|
165 | (4) |
|
6.5 Analyzing the Affected Metabolic Pathways |
|
|
169 | (2) |
|
6.6 Gene Expression Profiling: Part of a Toolbox for Mode of Action Determination |
|
|
171 | (4) |
|
|
172 | (3) |
|
7 Modern Approaches for Elucidating the Mode of Action of Neuromuscular Insecticides |
|
|
175 | (22) |
|
|
|
175 | (1) |
|
7.2 Biochemical and Electrophysiological Approaches |
|
|
176 | (7) |
|
7.2.1 Biochemical Studies |
|
|
176 | (3) |
|
7.2.2 Electrophysiological Studies on Native and Expressed Targets |
|
|
179 | (1) |
|
7.2.2.1 Whole-Cell Voltage Clamp Studies |
|
|
179 | (1) |
|
7.2.2.2 Oocyte Expression Studies |
|
|
180 | (2) |
|
7.2.3 Automated Two-Electrode Voltage-Clamp TEVC Recording Platforms |
|
|
182 | (1) |
|
7.3 Fluorescence-Based Approaches for Mode of Action Elucidation |
|
|
183 | (4) |
|
7.3.1 Calcium-Sensitive Probes |
|
|
183 | (3) |
|
7.3.2 Voltage-Sensitive Probes |
|
|
186 | (1) |
|
7.4 Genomic Approaches for Target Site Elucidation |
|
|
187 | (4) |
|
7.4.1 Chemical-to-Gene Screening |
|
|
187 | (3) |
|
7.4.2 Double-Stranded RNA Interference |
|
|
190 | (1) |
|
|
191 | (1) |
|
|
191 | (6) |
|
|
192 | (5) |
|
8 New Targets for Fungicides |
|
|
197 | (20) |
|
|
|
8.1 Introduction: Current Fungicide Targets |
|
|
197 | (2) |
|
8.2 A Retrospective Look at the Discovery of Targets for Fungicides |
|
|
199 | (1) |
|
8.3 New Sources for New Fungicide Targets in the Future? |
|
|
199 | (1) |
|
8.4 Methods to Identify a Novel Target for a Given Compound |
|
|
200 | (2) |
|
8.4.1 Microscopy and Cellular Imaging |
|
|
200 | (1) |
|
8.4.2 Cultivation on Selective Media |
|
|
200 | (1) |
|
8.4.3 Incorporation of Isotopically Labeled Precursors and Metabolomics |
|
|
201 | (1) |
|
|
201 | (1) |
|
8.4.5 Resistance Mutant Screening |
|
|
201 | (1) |
|
8.4.6 Gene Expression Profiling and Proteomics |
|
|
202 | (1) |
|
8.5 Methods of Identifying Novel Targets without Pre-Existing Inhibitors |
|
|
202 | (11) |
|
8.5.1 Biochemical Ideas to Generate Novel Fungicide Targets |
|
|
203 | (1) |
|
8.5.2 Genomics and Proteomics |
|
|
203 | (10) |
|
|
213 | (1) |
|
|
213 | (1) |
|
8.8 Beneficial Side Effects of Commercial Fungicides |
|
|
214 | (1) |
|
|
214 | (3) |
|
|
214 | (3) |
|
Part III New Methods to Improve the Bioavailability of Active Ingredients |
|
|
217 | (90) |
|
9 New Formulation Developments |
|
|
219 | (30) |
|
|
|
|
219 | (4) |
|
9.2 Drivers for Formulation Type Decisions |
|
|
223 | (2) |
|
9.3 Description of Formulation Types, Their Properties, and Problems during Development |
|
|
225 | (10) |
|
9.3.1 Pesticides Dissolved in a Liquid Continuous Phase |
|
|
225 | (3) |
|
9.3.2 Crystalline Pesticides in a Liquid Continuous Phase |
|
|
228 | (4) |
|
9.3.3 Pesticides in a Solid Matrix |
|
|
232 | (3) |
|
9.4 Bioavailability Optimization |
|
|
235 | (11) |
|
9.4.1 Spray Formation and Retention |
|
|
236 | (2) |
|
9.4.2 Spray Deposit Formation and Properties |
|
|
238 | (2) |
|
9.4.3 Cuticular Penetration |
|
|
240 | (2) |
|
9.4.3.1 Cuticular Penetration Test |
|
|
242 | (1) |
|
9.4.3.2 Effect of Formulation on Cuticular Penetration |
|
|
243 | (3) |
|
9.5 Conclusions and Outlook |
|
|
246 | (3) |
|
|
247 | (2) |
|
10 Polymorphism and the Organic Solid State: Influence on the Optimization of Agrochemicals |
|
|
249 | (24) |
|
|
|
|
249 | (1) |
|
10.2 Theoretical Principles of Polymorphism |
|
|
250 | (5) |
|
|
250 | (1) |
|
10.2.2 Definition of Polymorphism |
|
|
251 | (1) |
|
|
251 | (1) |
|
10.2.3.1 Monotropism and Enantiotropism |
|
|
251 | (1) |
|
10.2.3.2 Energy Temperature Diagrams and the Rules |
|
|
252 | (2) |
|
10.2.4 Kinetics of Crystallization: Nucleation |
|
|
254 | (1) |
|
10.3 Analytical Characterization of Polymorphs |
|
|
255 | (13) |
|
10.3.1 Differential Thermal Analysis and Differential Scanning Calorimetry |
|
|
256 | (2) |
|
|
258 | (1) |
|
10.3.3 Hot-Stage Microscopy |
|
|
259 | (2) |
|
10.3.4 IR and Raman Spectroscopies |
|
|
261 | (4) |
|
|
265 | (3) |
|
10.4 Patentability of Polymorphs |
|
|
268 | (2) |
|
|
270 | (3) |
|
|
270 | (1) |
|
|
270 | (3) |
|
11 The Determination of Abraham Descriptors and Their Application to Crop Protection Research |
|
|
273 | (34) |
|
|
|
|
273 | (1) |
|
11.2 Definition of Abraham Descriptors |
|
|
274 | (1) |
|
11.3 Determination of Abraham Descriptors: General Approach |
|
|
275 | (6) |
|
11.3.1 V and E Descriptors |
|
|
276 | (1) |
|
11.3.2 A, B, and S Descriptors |
|
|
277 | (1) |
|
11.3.3 A, B, S, and L Descriptors |
|
|
277 | (1) |
|
11.3.4 LSER Equations for Use in Determining Descriptors |
|
|
278 | (2) |
|
11.3.5 Prediction of Abraham Descriptors |
|
|
280 | (1) |
|
11.4 Determination of Abraham Descriptors: Physical Properties |
|
|
281 | (2) |
|
11.5 Determination of Abraham Descriptors: Examples |
|
|
283 | (13) |
|
11.5.1 Herbicides: Diuron (1) |
|
|
284 | (1) |
|
11.5.2 Herbicides: Simazine (2) and Atrazine (3) |
|
|
285 | (3) |
|
11.5.3 Herbicides: Acetochlor (4) and Alachlor (5) |
|
|
288 | (1) |
|
11.5.4 Insecticides: Fipronil (6) |
|
|
289 | (1) |
|
11.5.5 Insecticides: Imidacloprid (7) |
|
|
290 | (2) |
|
11.5.6 Insecticides: Chlorantraniliprole (8) |
|
|
292 | (1) |
|
11.5.7 Insecticides: Thiamethoxam (9) |
|
|
293 | (1) |
|
11.5.8 Fungicides: Azoxystrobin (10) |
|
|
294 | (1) |
|
11.5.9 Plant Growth Regulator: Paclobutrazol (11) |
|
|
295 | (1) |
|
11.6 Application of Abraham Descriptors: Descriptor Profiles |
|
|
296 | (1) |
|
11.7 Application of Abraham Descriptors: LFER Analysis |
|
|
297 | (4) |
|
11.7.1 LFERs for RP-HPLC Systems |
|
|
297 | (2) |
|
11.7.2 LFERs for Soil Sorption Coefficient (Koc) |
|
|
299 | (1) |
|
11.7.3 LFERs for Partitioning into Plant Cuticles |
|
|
300 | (1) |
|
11.7.4 LFERs for Root Concentration Factor (RCF) |
|
|
300 | (1) |
|
11.7.5 LFER for Transpiration Stream Concentration Factor |
|
|
301 | (1) |
|
11.8 Application of Abraham Descriptors: Generality of Approach |
|
|
301 | (6) |
|
|
302 | (1) |
|
|
302 | (5) |
|
Part IV Modern Methods for Risk Assessment |
|
|
307 | (94) |
|
12 Ecological Modeling in Pesticide Risk Assessment: Chances and Challenges |
|
|
309 | (26) |
|
|
|
309 | (2) |
|
12.2 Ecological Models in the Regulatory Environment |
|
|
311 | (4) |
|
12.2.1 Consideration of Realistic Exposure Patterns |
|
|
312 | (1) |
|
12.2.2 Extrapolation to Population Level: The Link to Protection Goals |
|
|
313 | (1) |
|
12.2.3 Extrapolation to Organization Levels above Populations |
|
|
314 | (1) |
|
12.3 An Overview of Model Approaches |
|
|
315 | (13) |
|
12.3.1 Toxicokinetic Models |
|
|
316 | (3) |
|
|
319 | (1) |
|
12.3.2.1 Differential Equation Models |
|
|
319 | (1) |
|
|
320 | (2) |
|
12.3.2.3 Individual-Based Models |
|
|
322 | (3) |
|
12.3.3 Ecosystem or Food-Web Models |
|
|
325 | (3) |
|
12.4 Regulatory Challenges |
|
|
328 | (7) |
|
|
331 | (4) |
|
13 The Use of Metabolomics In Vivo for the Development of Agrochemical Products |
|
|
335 | (16) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
13.1 Introduction to Metabolomics |
|
|
335 | (1) |
|
13.2 MetaMap®Tox Data Base |
|
|
336 | (1) |
|
|
336 | (1) |
|
13.2.1.1 Animal Treatment and Maintenance Conditions |
|
|
336 | (1) |
|
13.2.1.2 Blood Sampling and Metabolite Profiling |
|
|
336 | (1) |
|
13.3 Evaluation of Metabolome Data |
|
|
337 | (2) |
|
|
337 | (1) |
|
13.3.1.1 Metabolite Profiling |
|
|
337 | (1) |
|
13.3.1.2 Metabolome Patterns |
|
|
337 | (1) |
|
13.3.1.3 Whole-Profile Comparison |
|
|
338 | (1) |
|
13.4 Use of Metabolome Data for Development of Agrochemicals |
|
|
339 | (6) |
|
13.4.1 General Applicability |
|
|
339 | (1) |
|
|
339 | (1) |
|
13.4.2.1 Liver Enzyme Induction |
|
|
339 | (3) |
|
|
342 | (2) |
|
13.4.3 Chemical Categories |
|
|
344 | (1) |
|
|
345 | (2) |
|
13.5.1 Challenges and Chances Concerning the Use of Metabolite Profiling in Toxicology |
|
|
345 | (2) |
|
13.5.2 Applicability of the MetaMap®Tox Data Base |
|
|
347 | (1) |
|
|
347 | (4) |
|
|
348 | (3) |
|
14 Safety Evaluation of New Pesticide Active Ingredients: Enquiry-Led Approach to Data Generation |
|
|
351 | (30) |
|
|
|
351 | (3) |
|
14.2 What Is the Purpose of Mammalian Toxicity Studies? |
|
|
354 | (4) |
|
14.3 Addressing the Knowledge Needs of Risk Assessors |
|
|
358 | (4) |
|
14.4 Opportunities for Generating Data of Direct Relevance to Human Health Risk Assessment within the Existing Testing Paradigm |
|
|
362 | (5) |
|
14.4.1 Dose Selection for Carcinogenicity Studies |
|
|
362 | (3) |
|
14.4.2 Integrating Toxicokinetics into Toxicity Study Designs |
|
|
365 | (2) |
|
14.5 Enquiry-Led Data Generation Strategies |
|
|
367 | (4) |
|
14.5.1 Key Questions to Consider While Identifying Lead Molecules |
|
|
369 | (1) |
|
14.5.2 Key Questions to Consider When Selecting Candidates for Full Development |
|
|
370 | (1) |
|
14.5.3 Key Questions to Consider for a Compound in Full Development |
|
|
371 | (1) |
|
|
371 | (10) |
|
|
378 | (3) |
|
15 Endocrine Disruption: Definition and Screening Aspects in the Light of the European Crop Protection Law |
|
|
381 | (20) |
|
|
|
|
|
|
|
|
381 | (1) |
|
15.2 Endocrine Disruption: Definitions |
|
|
382 | (1) |
|
15.3 Current Regulatory Situation in the EU |
|
|
382 | (2) |
|
15.4 US EPA Endocrine Disruptor Screening Program and OECD Conceptual Framework for the Testing and Assessment of Endocrine-Disrupting Chemicals |
|
|
384 | (1) |
|
|
385 | (3) |
|
15.6 Methods to Assess Endocrine Modes of Action and Endocrine-Related Adverse Effects in Screening and Regulatory Contexts |
|
|
388 | (9) |
|
|
388 | (3) |
|
|
391 | (6) |
|
15.7 Proposal for Decision Criteria for EDCs: Regulatory Agencies |
|
|
397 | (4) |
|
|
397 | (4) |
Index |
|
401 | |